中西医结合治疗桥本甲状腺炎的研究进展
Research Progress on Integrated Traditional Chinese and Western Medicine in the Treatment of Hashimoto’s Thyroiditis
DOI: 10.12677/acm.2025.1551613, PDF,   
作者: 陈浩然*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;王宽宇#:黑龙江中医药大学附属第一医院外二科,黑龙江 哈尔滨
关键词: 桥本甲状腺炎中西医结合免疫调节临床疗效治疗方案Hashimoto’s Thyroiditis Integrated Traditional Chinese and Western Medicine Immune Regulation Clinical Efficacy Treatment Plans
摘要: 目的:探讨中西医结合治疗桥本甲状腺炎的研究进展,分析其在免疫调节及临床应用中的效果与机制。方法:通过回顾文献,分析西医治疗桥本甲状腺炎的局限性,以及中医药在调节免疫、改善炎症方面的潜力,探讨中西医结合治疗的优势。结果:西医激素替代疗法能缓解症状,但对免疫系统调控有限,且长期使用可能引发副作用。中医药通过辨证论治和调节免疫功能,能够有效降低抗体水平,减轻甲状腺炎症,改善患者生活质量。结论:中西医结合治疗在免疫调节和减轻炎症方面效果显著,具有较高临床应用价值。未来应加强大规模临床试验和个性化治疗方案的研究,以进一步验证其有效性与安全性。
Abstract: Objective: This paper reviews the latest progress in integrated traditional Chinese and Western medicine for treating Hashimoto’s thyroiditis (HT), focusing on its effects and mechanisms in immune regulation and clinical application. Methods: A literature review was conducted to analyze the limitations of Western medicine in treating HT and the potential of Chinese medicine in immune regulation and inflammation control, exploring the benefits of combined therapy. Results: While hormone replacement therapy relieves symptoms, its impact on immune regulation is limited, and long-term use may cause side effects. Chinese medicine, through syndrome differentiation and immune modulation, effectively reduces antibody levels, alleviates thyroid inflammation, and improves patients’ quality of life. Conclusion: Integrated traditional Chinese and Western medicine shows promising clinical efficacy, particularly in immune modulation and inflammation reduction. Future research should focus on large-scale clinical trials and personalized treatment plans to further confirm its effectiveness and safety.
文章引用:陈浩然, 王宽宇. 中西医结合治疗桥本甲状腺炎的研究进展[J]. 临床医学进展, 2025, 15(5): 2233-2238. https://doi.org/10.12677/acm.2025.1551613

参考文献

[1] 俎景林. 左旋甲状腺素抑制疗法对女性桥本甲状腺炎的治疗效果[J]. 河南医学研究, 2019, 28(24): 4481-4483.
[2] Yu, O.H.Y., Filliter, C., Filion, K.B., Platt, R.W., Grad, R. and Renoux, C. (2024) Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular Events. Thyroid®, 34, 1214-1224. [Google Scholar] [CrossRef] [PubMed]
[3] Ralli, M., Angeletti, D., Fiore, M., D’Aguanno, V., Lambiase, A., Artico, M., et al. (2020) Hashimoto’s Thyroiditis: An Update on Pathogenic Mechanisms, Diagnostic Protocols, Therapeutic Strategies, and Potential Malignant Transformation. Autoimmunity Reviews, 19, Article ID: 102649. [Google Scholar] [CrossRef] [PubMed]
[4] Caturegli, P., De Remigis, A. and Rose, N.R. (2014) Hashimoto Thyroiditis: Clinical and Diagnostic Criteria. Autoimmunity Reviews, 13, 391-397. [Google Scholar] [CrossRef] [PubMed]
[5] Hu, Y., Zhang, L., Chen, H., Liu, X., Zheng, X., Shi, H., et al. (2019) Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis. International Journal of Endocrinology, 2019, Article ID: 5368473. [Google Scholar] [CrossRef] [PubMed]
[6] 邓斌, 李敏州, 张慧艳, 等. 中医药治疗桥本氏甲状腺炎的研究进展[J]. 内蒙古医学杂志, 2024, 56(12): 1447-1449+1455.
[7] Luo, L., Nong Wang, J., Kong, L.D., Jiang, Q.G. and Tan, R.X. (2000) Antidepressant Effects of Banxia Houpu Decoction, a Traditional Chinese Medicinal Empirical Formula. Journal of Ethnopharmacology, 73, 277-281. [Google Scholar] [CrossRef] [PubMed]
[8] Tao, Y., Li, Q., Li, C. and Huo, J. (2023) Efficacy of Chinese Medicine in the Adjuvant Treatment of Hashimoto’s Thyroiditis with Hypothyroidism: A Systematic Review and Meta-Analysis. Biotechnology and Genetic Engineering Reviews, 40, 492-518. [Google Scholar] [CrossRef] [PubMed]
[9] Wu, X., Yang, H., Chen, X., Gao, J., Duan, Y., Wei, D., et al. (2021) Nano-Herb Medicine and PDT Induced Synergistic Immunotherapy for Colon Cancer Treatment. Biomaterials, 269, Article ID: 120654. [Google Scholar] [CrossRef] [PubMed]
[10] 曾雯, 周胜强, 黄佳, 等. 黄芪免疫调节活性成分及其药理作用进展[J]. 上海中医药杂志, 2025, 59(1): 80-88.
[11] Yakubogullari, N., Cagir, A., Bedir, E. and Sag, D. (2023) Astragalus Saponins, Astragaloside VII and Newly Synthesized Derivatives, Induce Dendritic Cell Maturation and T Cell Activation. Vaccines, 11, Article No. 495. [Google Scholar] [CrossRef] [PubMed]
[12] Zhu, H., Mu, S., Liu, S., Cui, Y., Ren, J., Yang, E., et al. (2024) Yiqi Jiedu Xiaoying Decoction Improves Experimental Autoimmune Thyroiditis in Rats by Regulating Th17/Treg Cell Balance. Endocrine, Metabolic & Immune DisordersDrug Targets, 24, 1186-1196. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, S., Ziros, P.G., Chartoumpekis, D.V., Psarias, G., Duntas, L., Zuo, X., et al. (2024) Traditional Chinese Medicine for Hashimoto’s Thyroiditis: Focus on Selenium and Antioxidant Phytochemicals. Antioxidants, 13, Article No. 868. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, S., Zhao, J., Zeng, W., Du, W., Zhong, T., Gao, H., et al. (2021) Acupuncture for Hashimoto Thyroiditis: Study Protocol for a Randomized Controlled Trial. Trials, 22, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[15] 李春霞, 薛延辉. 加味柴胡疏肝散联合左旋甲状腺素治疗桥本甲状腺炎伴甲减23例[J]. 中国现代药物应用, 2013, 7(17): 143-144.
[16] Li, H., Zheng, P., Min, J., Zhang, Y., Wang, W., Zhang, J., et al. (2020) A Prospective Randomized Controlled Clinical Trial of Pingmu Decoction Combined with Acupuncture in the Treatment of Non-Active Thyroid-Related Ophthalmopathy. Medicine, 99, e23734. [Google Scholar] [CrossRef] [PubMed]
[17] Trifirò, G., Parrino, F., Sultana, J., Giorgianni, F., Ferrajolo, C., Bianchini, E., et al. (2015) Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice. Clinical Drug Investigation, 35, 187-195. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, L., Luo, J., Sun, A., Yang, H., Lin, Y. and Han, L. (2024) Clinical Efficacy and Molecular Mechanism of Chinese Medicine in the Treatment of Autoimmune Thyroiditis. Journal of Ethnopharmacology, 323, Article ID: 117689. [Google Scholar] [CrossRef] [PubMed]
[19] 刘智艳, 姚小红. 针灸调节下丘脑-垂体-甲状腺轴的研究进展[J]. 针灸临床杂志, 2003(12): 50-51.